The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time
Brackground
We aimed to examine associations between elevated symptoms of depression and anxiety and disease activity in inflammatory bowel disease (IBD). Previous findings have been inconsistent and have not accounted for variability in the courses of these conditions over time.
Methods
We followed 247 participants with IBD (153 Crohn’s disease [CD], 94 ulcerative colitis [UC]) for 3 years. Annually, participants underwent an abdominal examination, reported therapies used for IBD, and completed the Hospital Anxiety and Depression Scale (HADS) questionnaire. We evaluated associations of elevated symptoms (scores ≥11) of anxiety (HADS-A) and depression (HADS-D) with the presence of active IBD as measured using the Powell Tuck Index for UC and the Harvey-Bradshaw Disease Activity Index for CD. We employed logistic regression with generalized estimating equations, simultaneously estimating between-person and within-person effects.
Results
Of 247 participants, 15 (6.1%) had elevated symptoms of depression (HADS-D ≥11) at enrollment, 41 (16.6%) had elevated symptoms of anxiety (HADS-A ≥11), and 101 (40.9%) had active IBD. On average, individuals with elevated symptoms of depression (odds ratio [OR], 6.27; 95% CI, 1.39–28.2) and anxiety (OR, 2.17; 95% CI, 1.01–4.66) had increased odds of active IBD. Within individuals, elevations in symptoms of depression over time were associated with increased odds of active IBD (OR, 2.70; 95% CI, 1.15–6.34), but elevated symptoms of anxiety were not. After adjustment for covariates (including disease activity), elevated symptoms of depression were also associated with increased odds of biologic therapy use (OR, 2.02; 95% CI, 1.02–4.00).
Conclusion
Symptoms of depression and anxiety are associated with disease activity in IBD over time. Reducing these symptoms should be incorporated into the management of IBD.
Top-30
Journals
|
1
2
3
4
|
|
|
Scientific Reports
4 publications, 4.12%
|
|
|
Alimentary Pharmacology and Therapeutics
4 publications, 4.12%
|
|
|
Journal of Clinical Medicine
3 publications, 3.09%
|
|
|
Frontiers in Immunology
3 publications, 3.09%
|
|
|
Crohn s & Colitis 360
3 publications, 3.09%
|
|
|
Inflammatory Bowel Diseases
3 publications, 3.09%
|
|
|
BMC Gastroenterology
3 publications, 3.09%
|
|
|
Journal of Clinical Gastroenterology
2 publications, 2.06%
|
|
|
General Hospital Psychiatry
2 publications, 2.06%
|
|
|
Gastroenterology
2 publications, 2.06%
|
|
|
Gastroenterología y Hepatología (English Edition)
2 publications, 2.06%
|
|
|
Gastroenterologia y Hepatologia
2 publications, 2.06%
|
|
|
Internal and Emergency Medicine
2 publications, 2.06%
|
|
|
Gut Microbes
2 publications, 2.06%
|
|
|
Journal of the Canadian Association of Gastroenterology
2 publications, 2.06%
|
|
|
Journal of Crohn's and Colitis
2 publications, 2.06%
|
|
|
Frontiers in Psychiatry
2 publications, 2.06%
|
|
|
Journal of Health Psychology
2 publications, 2.06%
|
|
|
Frontiers in Medicine
1 publication, 1.03%
|
|
|
Life
1 publication, 1.03%
|
|
|
Frontiers in Neurology
1 publication, 1.03%
|
|
|
Journal of Clinical Psychology in Medical Settings
1 publication, 1.03%
|
|
|
Nature Reviews Gastroenterology and Hepatology
1 publication, 1.03%
|
|
|
Microbiome
1 publication, 1.03%
|
|
|
Physiology and Behavior
1 publication, 1.03%
|
|
|
Neurogastroenterology and Motility
1 publication, 1.03%
|
|
|
Clinical and Experimental Gastroenterology
1 publication, 1.03%
|
|
|
Gut
1 publication, 1.03%
|
|
|
Biochemical and Biophysical Research Communications
1 publication, 1.03%
|
|
|
1
2
3
4
|
Publishers
|
2
4
6
8
10
12
14
16
18
20
|
|
|
Springer Nature
19 publications, 19.59%
|
|
|
Elsevier
17 publications, 17.53%
|
|
|
Wiley
11 publications, 11.34%
|
|
|
Oxford University Press
10 publications, 10.31%
|
|
|
MDPI
7 publications, 7.22%
|
|
|
Frontiers Media S.A.
7 publications, 7.22%
|
|
|
Taylor & Francis
7 publications, 7.22%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
5 publications, 5.15%
|
|
|
SAGE
3 publications, 3.09%
|
|
|
BMJ
2 publications, 2.06%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 2.06%
|
|
|
Baishideng Publishing Group
2 publications, 2.06%
|
|
|
Research Square Platform LLC
1 publication, 1.03%
|
|
|
JMIR Publications
1 publication, 1.03%
|
|
|
American Chemical Society (ACS)
1 publication, 1.03%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.